微柱凝胶技术与凝聚胺技术在ABO新生儿溶血病输血前检测中应用对比  

Comparison of Microcolumn Gel Technique and Polyamine Technique in the Detection of ABO hemolytic Disease of Newborn before Blood Transfusion

作　　者：张冰[1] 宋小彦 崔静辉 ZHANG Bing;SONG Xiaoyan;CUI Jinghui(Department of Blood Transfusion,Zhengzhou First People's Hospital,Zhengzhou Henan 450000,China)

机构地区：[1]郑州市第一人民医院输血科,河南郑州450000

出　　处：《临床研究》2024年第3期109-111,共3页Clinical Research

摘　　要：目的对比分析微柱凝胶技术与凝聚胺技术在ABO新生儿溶血病输血前检测中的应用。方法将郑州市第一人民医院2020年1月至2023年5月ABO新生儿溶血病患儿(88例)作为研究对象,依据区间随机法将其分为对照组、研究组,各纳入44例,对照组行输血治疗前开展凝聚胺技术检验血型配血,研究组输血治疗前开展微柱凝胶技术检验血型配血。比较两组检验符合率、一次性交叉配血成功率。结果研究组正定型、反定型符合率(100.00%、100.00%)均高于对照组(86.36%、86.36%),两组差异有统计学意义(P<0.05);研究组交叉配血成功率(100.00%)高于对照组(86.36%),两组差异有统计学意义(P<0.05)。结论对比凝聚胺技术,微柱凝胶技术在ABO新生儿溶血病输血前检测中的应用价值更高,有利于提升输血安全,值得应用。Objective To compare and analyze the application of microcolumn gel technique and polyamine technique in the detection of ABO hemolytic disease of newborn before blood transfusion.Methods From January 2020 to May 2023 in the First People's Hospital of Zhengzhou City,88 children with ABO hemolytic disease of newborn(88 cases)were taken as the research object,and they were divided into the control group and the study group according to the interval random method,44 cases were included in each group.Before blood transfusion,the control group carried out the blood type matching test with the technology of polyamine,and the study group carried out the blood type matching test with the technology of microcolumn gel.The compliance rate and success rate of one-time cross matching between two groups of tests were compared.Results The conformity rates of positive and negative stereotypes in the study group(100.00%,100.00%)were higher than those in the control group(86.36%,86.36%),and the difference between the two groups was statistically significant(P<0.05);The success rate of cross matching in the study group(100.00%)was higher than that in the control group(86.36%),and the difference between the two groups was statistically significant(P<0.05).Conclusion Compared with the polyamine technology,the microcolumn gel technology has a higher application value in the detection of ABO hemolytic disease of newborn before blood transfusion,which is conducive to improving the safety of blood transfusion and is worthy of application.

关 键 词：微柱凝胶技术 凝聚胺技术 ABO新生儿溶血病 输血前检测 输血安全 

分 类 号：R556.63[医药卫生—血液循环系统疾病]